We take great pleasure in welcoming you to our ProMyelo GmbH homepage and would like to thank you for your interest in our services and Multiple Sclerosis Research & Development activities. Today more than ever before, successful and efficient research requires the use of the very latest methods and demands the highest possible level of technical skills.
ProMyelo GmbH is a highly specialized preclinical research organization offering services that focus on the development of new neural therapies, especially in the field of Multiple Sclerosis research. ProMyelo’s various preclinical MS model Systems (cuprizone, EAE, LPC etc.) and applications (immunohistochemistry, ultrastructural analyses, gene expression studies, cell culture approaches, etc.) provide high-quality standard and customizable solutions for basic science, preclinical and clinical research. We provide these specialized research services to pharmaceutical & biotechnology companies, non-profit organizations and academic researchers.
We identify neurodegeneration as a potent trigger for peripheral immune cell recruitment into the forebrain. This novel MS animal model allows to study separately the impact of pharmacological intervention on (i) inflammation and (ii) brain intrinsic degeneration. The manuscript was accepted in January 2016 in The Journal of Neurosciences.
MS animal models
If you are interested in our different multiple sclerosis animal models for preclinical research, plase click here
In vitro Assays
If you are interested in our in vitro assay systems to study oligodendrocyte proliferation and differentiation, please click here
If you would like us to perform high quality (immuno-) histochemistry and unbiased quantification, please click here
Project planning and data evaluation
Please click here for contacting us